Detalhe da pesquisa
1.
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study.
BMC Pediatr
; 19(1): 50, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30732648
2.
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults.
Hum Vaccin Immunother
; 18(1): 1981085, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614379